- Home
- BLD vs MRNA Comparison
BLD vs MRNA Comparison
Compare BLD & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLD | MRNA |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 11.5B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | BLD | MRNA |
|---|---|---|
| Price | $550.90 | $42.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 11 |
| Target Price | ★ $444.14 | $30.80 |
| AVG Volume (30 Days) | 285.3K | ★ 13.5M |
| Earning Date | 02-26-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 19.67 | N/A |
| Revenue | ★ $5,236,045,000.00 | $1,944,000,000.00 |
| Revenue This Year | $2.61 | $5.45 |
| Revenue Next Year | $13.86 | $14.54 |
| P/E Ratio | $28.01 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $266.26 | $22.28 |
| 52 Week High | $555.85 | $55.20 |
Technical Indicators
Market Signals| Indicator | BLD | MRNA |
|---|---|---|
| Relative Strength Index (RSI) | 72.31 | 54.21 |
| Support Level | $521.03 | $36.66 |
| Resistance Level | $555.85 | $45.50 |
| Average True Range (ATR) | 18.20 | 3.14 |
| MACD | 5.16 | -0.86 |
| Stochastic Oscillator | 94.78 | 38.86 |
Price Performance
Historical ComparisonAbout BLD TopBuild Corp.
TopBuild Corp is an installer and distributor of insulation products. Its operating segments involve the Installation and Specialty Distribution segment. The installation segment provides insulation installation services nationwide through contractor services business. Speciality Distribution segment distributes building and mechanical insulation, insulation accessories and other building product materials for the residential, commercial, and industrial end markets. The majority of revenue is earned from the installation segment. Its main customers are contractors. Other products include gutters, after-paint, garage doors, fireplaces, and fireproofing and stopping. TopBuild operates majorly in the United States.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.